Vanguard Group’s Aprea Therapeutics APRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Hold |
173,842
| – | – | ﹤0.01% | 4027 |
|
|
2025
Q1 | $355K | Hold |
173,842
| – | – | ﹤0.01% | 3961 |
|
|
2024
Q4 | $570K | Hold |
173,842
| – | – | ﹤0.01% | 3915 |
|
|
2024
Q3 | $478K | Buy |
173,842
+58,004
| +50% | +$160K | ﹤0.01% | 3981 |
|
|
2024
Q2 | $471K | Sell |
115,838
-140
| -0.1% | -$570 | ﹤0.01% | 4027 |
|
|
2024
Q1 | $776K | Buy |
115,978
+81,290
| +234% | +$544K | ﹤0.01% | 3892 |
|
|
2023
Q4 | $163K | Buy |
34,688
+7,347
| +27% | +$34.5K | ﹤0.01% | 4249 |
|
|
2023
Q3 | $114K | Buy |
27,341
+11,840
| +76% | +$49.3K | ﹤0.01% | 4334 |
|
|
2023
Q2 | $48.8K | Hold |
15,501
| – | – | ﹤0.01% | 4459 |
|
|
2023
Q1 | $68.8K | Sell |
15,501
-294,528
| -95% | -$1.31M | ﹤0.01% | 4437 |
|
|
2022
Q4 | $103K | Buy |
310,029
+431
| +0.1% | +$143 | ﹤0.01% | 4392 |
|
|
2022
Q3 | $201K | Sell |
309,598
-45,892
| -13% | -$29.8K | ﹤0.01% | 4415 |
|
|
2022
Q2 | $266K | Hold |
355,490
| – | – | ﹤0.01% | 4428 |
|
|
2022
Q1 | $662K | Sell |
355,490
-341,336
| -49% | -$636K | ﹤0.01% | 4327 |
|
|
2021
Q4 | $2M | Sell |
696,826
-20,589
| -3% | -$59.1K | ﹤0.01% | 4039 |
|
|
2021
Q3 | $3.67M | Buy |
717,415
+9,993
| +1% | +$51.1K | ﹤0.01% | 3827 |
|
|
2021
Q2 | $3.45M | Sell |
707,422
-45,312
| -6% | -$221K | ﹤0.01% | 3772 |
|
|
2021
Q1 | $3.84M | Buy |
752,734
+3,020
| +0.4% | +$15.4K | ﹤0.01% | 3662 |
|
|
2020
Q4 | $3.69M | Buy |
749,714
+106,524
| +17% | +$524K | ﹤0.01% | 3488 |
|
|
2020
Q3 | $15.5M | Buy |
643,190
+38,813
| +6% | +$934K | ﹤0.01% | 2575 |
|
|
2020
Q2 | $23.4M | Buy |
604,377
+335,926
| +125% | +$13M | ﹤0.01% | 2346 |
|
|
2020
Q1 | $9.33M | Buy |
268,451
+6,455
| +2% | +$224K | ﹤0.01% | 2654 |
|
|
2019
Q4 | $12M | Buy |
+261,996
| New | +$12M | ﹤0.01% | 2771 |
|